Ignite Creation Date:
2024-05-05 @ 11:44 AM
Last Modification Date:
2024-10-26 @ 9:12 AM
Study NCT ID:
NCT00115206
Status:
COMPLETED
Last Update Posted:
2009-04-06
First Post:
2005-06-21
Brief Title:
Neulasta in Subjects With Advanced Non-Small-Cell Lung Cancer NSCLC During Chemotherapy
Sponsor:
Amgen
Organization:
Amgen
Study Overview
Official Title:
A Pilot Study of the Effects of Neutropenia on Patient Reported Outcomes During Chemotherapy With or Without Neulasta Pegfilgrastim in Subjects With Advanced NSCLC
Status:
COMPLETED
Status Verified Date:
2009-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to estimate the relationship between patient reported outcomes PROs and neutropenia or its complications in NSCLC subjects receiving chemotherapy with or without Neulasta pegfilgrastim
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None